Guidelines on diagnosis and treatment of pulmonary arterial hypertension -: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

被引：857

作者：

Galiè, N ^{[1
]}

Torbicki, A ^{[1
]}

Barst, R ^{[1
]}

Dartevelle, P ^{[1
]}

Haworth, S ^{[1
]}

Higenbottam, T ^{[1
]}

Olschewski, H ^{[1
]}

Peacock, A ^{[1
]}

Pietra, G ^{[1
]}

Rubin, LJ ^{[1
]}

Simonneau, G ^{[1
]}

机构：

[1] Univ Bologna, Inst Cardiol, I-40138 Bologna, Italy

来源：

EUROPEAN HEART JOURNAL | 2004年 / 25卷 / 24期

关键词：

D O I：

10.1016/j.ehj.2004.09.014

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2243 / 2278

页数：36

共 229 条

[1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].

Abenhaim, L ;

Moride, Y ;

Brenot, F ;

Rich, S ;

Benichou, J ;

Kurz, X ;

Higenbottam, T ;

Oakley, C ;

Wouters, E ;

Aubier, M ;

Simonneau, G ;

Begaud, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616

[2]

Abrams D, 2000, Heart, V84, pE4, DOI 10.1136/heart.84.2.e4

[3] Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension [J].

Aguilar, RV ;

Farber, HW .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) :1846-1850

[4] Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease [J].

Ahearn, GS ;

Tapson, VF ;

Rebeiz, A ;

Greenfield, JC .

CHEST, 2002, 122 (02) :524-527

[5] Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent [J].

Albrecht, T ;

Blomley, MJK ;

Cosgrove, DO ;

Taylor-Robinson, SD ;

Jayaram, V ;

Eckersley, R ;

Urbank, A ;

Butler-Barnes, J ;

Patel, N .

LANCET, 1999, 353 (9164) :1579-1583

[6] Pulmonary arterial hypertension in previously splenectomized patients with β-thalassemic disorders [J].

Atichartakarn, V ;

Likittanasombat, K ;

Chuncharunee, S ;

Chandanamattha, P ;

Worapongpaiboon, S ;

Angchaisuksiri, P ;

Aryurachai, K .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (02) :139-145

[7] EXPERIMENTAL STUDIES OF SURGICAL TREATMENT OF PRIMARY PULMONARY HYPERTENSION [J].

AUSTEN, WG ;

BERRY, WB ;

MORROW, AG .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1964, 48 (03) :448-+

[8] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].

Badesch, DB ;

Tapson, VF ;

McGoon, MD ;

Brundage, BH ;

Rubin, LJ ;

Wigley, FM ;

Rich, S ;

Barst, RJ ;

Barrett, PS ;

Kral, KM ;

Jöbsis, MM ;

Loyd, JE ;

Murali, S ;

Frost, A ;

Girgis, R ;

Bourge, RC ;

Ralph, DD ;

Elliott, CG ;

Hill, NS ;

Langleben, D ;

Schilz, RJ ;

McLaughlin, VV ;

Robbins, IM ;

Groves, BM ;

Shapiro, S ;

Medsger, TA ;

Gaine, SP ;

Horn, E ;

Decker, JC ;

Knobil, K .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+

[9] Medical therapy for pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines [J].

Badesch, DB ;

Abman, SH ;

Ahearn, GS ;

Barst, RJ ;

McCrory, DC ;

Simonneau, G ;

McLaughlin, VV .

CHEST, 2004, 126 (01) :35S-62S

[10] Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's disease [J].

Bakst, AE ;

Gaine, SP ;

Rubin, LJ .

CHEST, 1999, 116 (04) :1127-+

← 1 2 3 4 5 6 7 8 9 10 →